Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
The 3 Best Blue-Chip Stocks to Buy Now
02:43pm, Wednesday, 03'rd Jan 2024
Growth stocks sound exciting as they represent high-growth companies that could create immense value. Penny stocks are similar as they have a high degree of speculation.
Vaccine Stock the Worst to Own in January, Historically
02:22pm, Wednesday, 03'rd Jan 2024
Pfizer Inc (NYSE:PFE) stock moved steadily lower in 2023, closing 11 out of 12 months lower, with March as the only gainer.
7 Most Undervalued Stocks to Buy Now
01:47pm, Wednesday, 03'rd Jan 2024
The start of a New Year is a good time to scrutinize a portfolio and make some adjustments including adding undervalued stocks. Stocks that enjoyed big runs last year may cool off, requiring investors
Pfizer: If You Missed The Pandemic Entry, Here's Another Chance
11:52am, Wednesday, 03'rd Jan 2024
Pfizer remains a strong investment opportunity with a diverse product portfolio and solid financials despite a decline in revenue due to the end of the pandemic. The company has demonstrated resilienc
Canada approves Pfizer's gene therapy for bleeding disorder
08:30am, Wednesday, 03'rd Jan 2024
Pfizer said on Wednesday that Canada's health regulator approved its gene therapy for the treatment of a rare inherited bleeding disorder called hemophilia B.
Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference
10:00am, Tuesday, 02'nd Jan 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to listen to a webcast of a discussion with Albert Bourla, Chairman and Chief Executive Officer, at the 42nd
Revealed: The most disappointing stocks of 2023
09:08am, Sunday, 31'st Dec 2023
The general stock market is concluding 2023 on a positive note, propelled by specific equities that have spearheaded an end-of-year rally. Significantly, these gains have enabled several stocks to rec
Pfizer, big drugmakers expected to hike prices on at least 500 drugs in January
11:55am, Friday, 29'th Dec 2023
The expected price hikes come as the pharmaceutical industry gears up for the Biden Administration to publish significantly discounted prices for 10 high-cost drugs in September, and continues to cont
Here are the 20 worst-performing stocks among the S&P 500 in 2023
11:18am, Friday, 29'th Dec 2023
The U.S. stock market staged a remarkable rally in 2023, but 173 stocks in the S&P 500 were still down for the year.
Dividend Harvesting Portfolio Week 147: $14,700 Allocated, $1,301.37 In Projected Dividends
09:00am, Thursday, 28'th Dec 2023
Dividend Harvesting Portfolio Week 147: $14,700 Allocated, $1,301.37 In Projected Dividends
Interested in the Weight-Loss Market? Here's 1 Stock to Buy Hand Over Fist in 2024, and 1 to Avoid Like the Plague.
08:30am, Thursday, 28'th Dec 2023
Eli Lilly is the developer of Mounjaro, a diabetes treatment generating billions in sales. Pfizer has had its challenges as it looks to enter the diabetes and obesity markets.
Could Pfizer Be a No-Brainer Stock to Buy Right Now, Even If Its COVID Sales Continue to Plunge?
05:50am, Thursday, 28'th Dec 2023
Pfizer's COVID-19 product revenue is sinking. Even in a worst-case scenario, though, Pfizer's valuation is much cheaper than its peers.
The Pfizer Advantage: High Dividend Yield, JN.1 Variant, And Therapeutic Innovations
01:30am, Thursday, 28'th Dec 2023
Pfizer is one of the largest American pharmaceutical companies, developing medicines and vaccines using cutting-edge technologies to save and improve the lives of millions worldwide. Pfizer's revenue
Top Performers: 7 High-Efficiency Stocks With Stellar Profit Per Employee Ratios
10:34pm, Wednesday, 27'th Dec 2023
Inundated with myriad ways of assessing publicly traded companies, one unique metric could intrigue investors seeking opportunities in 2024 and that would be high-efficiency stocks. However, rather th
Pfizer (PFE) Surpasses Market Returns: Some Facts Worth Knowing
06:47pm, Wednesday, 27'th Dec 2023
In the most recent trading session, Pfizer (PFE) closed at $28.61, indicating a +0.7% shift from the previous trading day.
